Portrai Platform

Portrai Platform

PortraiDISCOVERY

Analyze the pathophysiology of diseases
and discover biomarkers

We provide academically meaningful information by studying the pathophysiology of diseases.
Using Tissue microarray (TMA), which places multiple samples on one slide,
we can explore the differences between groups with just one slide.

Analysis Procedure

We analyze spatial transcriptomes for a statistically significant number of samples at a reasonable cost.

Usage Examples

PortraiDISCOVERY can be used like this:

PortraiTARGET

Identifying the Best Targets for Novel Drugs based on Big Data

Assists in decision-making for the expansion and termination of pipelines.
By using petabyte-scale human spatial transcriptomics and single-cell transcriptomics data that Portrai has already secured, along with AI algorithms, start drug development and biomarker discovery more efficiently.

Analysis Procedure

We provide evidence to help decide whether to proceed with drug development for a specific target.
After discussing various inquiries related to the target, we determine the scope and direction of the analysis.

Usage Examples

PortraiTARGET can be used like this:

How to Use

PortraiTARGET takes an average of 8-12 weeks* and the results are provided in the form of an interactive report.

*The duration may vary depending on the scope and complexity of the analysis.

PortraiDRUG/MIX

Combining Drug Distribution within Tissues
with Spatial Transcriptomics Information

Provides information necessary for licensing deals of drug assets and optimization of drug distribution.
Analyzes genes related to drug distribution within tissues.

Analysis Procedure

We provide evidence to help decide whether to proceed with drug development for a specific target.
After discussing various inquiries related to the drug, we determine the scope and direction of the analysis.

Usage Examples

PortraiDRUG and PortraiMIX can be used like this :

How to Use

PortraiDRUG/MIX takes an average of 16 weeks* and the results are provided in the form of an Interactive Report.

*Research timeline may vary depending on the scope and complexity of the analysis.

PortraiMOA

Analyzing the Increase and Decrease of Genes according to drug action

Provides meaningful information for licensing deals of drug assets.
Analyzes genes related to the action of the administered drug.
PortraiMOA is essential when the 'location' where the drug acts is important, such as in solid tumors and brain diseases.

Analysis Procedure

Provides information needed to compare and analyze the action and side effects of drugs.
After discussing various inquiries related to the drug, we determine the scope and direction of the analysis.

How to Use

PortraiMOA takes an average of 16 weeks* and the results are provided in the form of an Interactive Report.

*Research timeline may vary depending on the scope and complexity of the analysis.

PortraiTME

Discovering Biomarkers Based on H&E Images

By using the human spatial transcriptomics and single-cell transcriptomics data that Portrai has already secured, along with AI algorithms, we can combine these with H&E images to start drug development and biomarker discovery more efficiently.

Analysis Procedure

Provides evidence for the indication of drugs based on biomarkers.

How to Use

After model production, it takes an average of 1 week* to extract results, which can be viewed directly on the web.If combined with additional non-clinical/clinical outcomes, it takes an additional 1-2 weeks, and the results are provided as an analysis report.

*Research timeline may vary depending on the scope and complexity of the analysis.